NCT05871918 2023-05-23A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast CancerTianjin Medical University Cancer Institute and HospitalPhase 3 Unknown832 enrolled